Evidence map›Paper›PMID 33856965›Full record

ArticleAnnals of the American Thoracic Society2021

Population Genomics of

Rebecca M Davidson, Nabeeh A Hasan, L Elaine Epperson, Jeanne B Benoit, Sara M Kammlade, Adrah R Levin, Vinicius Calado de Moura, Joshua Hunkins, Natalia Weakly, Sean Beagle and 6 more

Open access · greenAbstract read
In one paragraph

Article in Annals of the American Thoracic Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Article
  3. Genome and drug resistance analysis ofFrontiers in microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Macrolide resistance inJAC-antimicrobial resistance · 2025
    Review
  8. Article
  9. Divergent host humoral innate immune response to the smooth-to-rough adaptation ofFrontiers in cellular and infection microbiology · 2025
    Article
  10. Genomic epidemiology ofERJ open research · 2024
    Article
  11. Review
  12. Journal of clinical microbiology · 2024
    Article
  13. Article
  14. Nitric oxide-releasing prodrug for the treatment of complexAntimicrobial agents and chemotherapy · 2024
    Article
  15. Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2024
    Observational
  16. Review
  17. Journal of clinical microbiology · 2023
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Rebecca M DavidsonCenter for Genes, Environment, and Health.
Nabeeh A HasanCenter for Genes, Environment, and Health.
L Elaine EppersonCenter for Genes, Environment, and Health.
Jeanne B BenoitCenter for Genes, Environment, and Health.
Sara M KammladeCenter for Genes, Environment, and Health.
Adrah R LevinDepartment of Medicine, National Jewish Health, Denver, Colorado.
Vinicius Calado de MouraMycobacteriology Laboratory, and.
Joshua HunkinsMycobacteriology Laboratory, and.
Natalia WeaklyCenter for Genes, Environment, and Health.
Sean BeagleCenter for Genes, Environment, and Health.
Scott D SagelDepartment of Pediatrics, Children's Hospital Colorado-School of Medicine, University of Colorado, Aurora, Colorado; and.ORCID 0000-0001-6172-4465
Stacey L MartinianoDepartment of Pediatrics, Children's Hospital Colorado-School of Medicine, University of Colorado, Aurora, Colorado; and.
Max SalfingerCollege of Public Health and.
Charles L DaleyDepartment of Medicine, National Jewish Health, Denver, Colorado.
Jerry A NickDepartment of Medicine, National Jewish Health, Denver, Colorado.
Michael StrongCenter for Genes, Environment, and Health.
National Jewish Health · USChildren's Hospital Colorado · USUniversity of South Florida · US

Funding

Viral-induced Adaptation of Neutrophil Response in ARDSR01HL090991 · NHLBI · NATIONAL JEWISH HEALTH · PI NICK, JERRY A · 2007 to 2010
$1.7M
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous MycobacteriaR01HL146228 · NHLBI · NATIONAL JEWISH HEALTH · PI HILL, JANE, NICK, JERRY A · 2019 to 2022
$1.7M
Genetic Epidemiology of Nontuberculous Mycobacteria for Predicting Host Specificity and Lung Disease OutcomesK01AI125726 · NIAID · NATIONAL JEWISH HEALTH · PI DAVIDSON, REBECCA · 2016 to 2020
$557k
NHLBI NIH HHS R01 HL090991NHLBI NIH HHS R01 HL146228NIAID NIH HHS K01 AI125726
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cystic FibrosisMycobacterium abscessusMycobacterium Infections, NontuberculousAnti-Bacterial AgentsGenomicsHumansMetagenomicsMicrobial Sensitivity TestsUnited StatesAnti-Bacterial Agentscystic fibrosisinfectious disease surveillanceMycobacterium abscessusnontuberculous mycobacteriaphylogenomics

Identifiers

PMID33856965
PMCPMC8641822
OpenAlexW3156878169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.